Hernández-Camba A., Arranz L., Vera I., Carpio D., Calafat M., Lucendo A.J., Taxonera C., Marín S., Garcia M.J., Marín G.S., Rodríguez E.S., Carbajo A.Y., De Castro M.L., Iborra M., Martin-Cardona A., Rodríguez-Lago I., Busquets D., Bertoletti F., Ausín M.S., Tardillo C., Malaves J.H., Bujanda L., Castaño A., Domènech E., Ramos L., Merino O.. Real-world use of mycophenolate mofetil in inflammatory bowel disease: Results from the ENEIDA registry. DIGESTIVE AND LIVER DISEASE. 2022; 54(5)DOI:10.1016/j.dld.2021.10.002. PMID:34862115. IF:4.500(Q2/4D).

Jimenez, C, Ventura-Cots, M, Sala, M, Calafat, M, Garcia-Retortillo, M, Cirera, I, Canete, N, Soriano, G, Poca, M, Simon-Talero, M, Altamirano, J, Lucey, M, Garcia-Tsao, G, Brown, RS, Schwabe, RF, Verna, EC, Schnabl, B, Bosques-Padilla, F, Mathurin, P, Caballeria, J, Louvet, A, Shawcross, DL, Abraldes, JG, Genesca, J, Bataller, R, Vargas, V. Effect of rifaximin on infections, acute-on-chronic liver failure and mortality in alcoholic hepatitis: A pilot study (RIFA-AH). LIVER INTERNATIONAL. 2022; 42(5)DOI:10.1111/liv.15207. PMID:35220659. IF:6.700(Q1/3D).

Molero X., Ayuso J.R., Balsells J., Boadas J., Busquets J., Casteràs A., Concepción M., Cuatrecasas M., Fernàndez Esparrach G., Fort E., Garcia Borobia F., Ginès À., Ilzarbe L., Loras C., Masachs M., Merino X., Olsina J.J., Puig-Diví V., Salord S., Serrano T., Vaquero E.C.. Chronic pancreatitis for the clinician. Part 2: Treatment and follow-up. Interdisciplinary Position Paper of the Societat Catalana de Digestologia and the Societat Catalana de Pancrees. Gastroenterologia y Hepatologia. 2022; 45(4)DOI:10.1016/j.gastrohep.2021.05.016. PMID:34171422. IF:1.900(Q4/10D).

Molero, X, Ayuso, JR, Balsells, J, Boadas, J, Busquets, J, Casteras, A, Concepcion, M, Cuatrecasas, M, Esparrach, GF, Fort, E, Borobia, FG, Gines, A, Ilzarbe, L, Loras, C, Masachs, M, Merino, X, Olsina, JJ, Puig-Divi, V, Salord, S, Serrano, T, Vaquero, EC. Chronic pancreatitis for the clinician. Part 1: Etiology and diagnosis. Interdisciplinary position paper of the Societat Catalana de Digestologia and the Societat Catalana de Pancrees. Gastroenterologia y Hepatologia. 2022; 45(3)DOI:10.1016/j.gastrohep.2021.05.017. PMID:34157366. IF:1.900(Q4/10D).

de Santiago, ER, Aldehuelo, RS, Pons, FR, Escaja, CR, Fernandez-Esparrach, G, Canete-Ruiz, A, Aracil, CF, Perez-Corte, D, Leon, RR, Marcos-Prieto, HM, Delgado-Guillena, PG, Garcia-Rodriguez, A, Guarner-Argente, C, Muriel, A, de la Fuente-Briongos, E, de Paredes, AGG, Parejo-Carbonell, S, Tellez, L, Senosiain-Lalastra, C, Burgos-Santamaria, D, Aicart-Ramos, M, Munoz, BM, Penas-Garcia, B, Pagano, G, Urquiza, GC, Ferreruela, MU, de Jorge-Turrion, MA, Barreiro-Alonso, E, Fraile-Lopez, M, Gomez-Outomuro, A, Altamirano, MI, Esteban, MN, Ruiz-Andreu, M, Arribas-Anta, J, de Frutos, D, Herreros-de-Tejada, A, Arias-Rivera, ML, Roldan-Fernandez, M, Martin, AFM, Zamora, J, Vazquez-Sequeiros, E, Albillos, A. Endoscopy-Related Bleeding and Thromboembolic Events in Patients on Direct Oral Anticoagulants or Vitamin K Antagonists. Clinical Gastroenterology and Hepatology. 2022; 20(3)DOI:10.1016/j.cgh.2020.11.037. PMID:33279783. IF:12.600(Q1/1D).

Gutierrez, A, Zapater, P, Ricart, E, Gonzalez-Vivo, M, Gordillo, J, Olivares, D, Vera, I, Manosa, M, Gisbert, JP, Aguas, M, Sanchez-Rodriguez, E, Bosca-Watts, M, Laredo, V, Camps, B, Marin-Jimenez, I, Zabana, Y, Martin-Arranz, MD, Munoz, R, Navarro, M, Sierra, E, Madero, L, Vela, M, Perez-Calle, JL, Sainz, E, Calvet, X, Arias, L, Morales, V, Bermejo, F, Fernandez-Salazar, L, Van Domselaar, M, De Castro, L, Rodriguez, C, Munoz-Villafranca, C, Lorente, R, Rivero, M, Iglesias, E, Herreros, B, Busquets, D, Riera, J, Martinez-Montiel, MP, Roldon, M, Roncero, O, Hinojosa, E, Sierra, M, Barrio, J, De Francisco, R, Huguet, J, Merino, O, Carpio, D, Ginard, D, Munoz, F, Marta, P, Almela, P, Argueelles-Arias, F, Alcain, G, Luis, B, Mancenido, N, Lucendo, AJ, Varela, P, Rodriguez-Lago, I, Ramos, L, Laura, S, Sese, E, Acosta, MBD, Domenech, E, Frances, R. Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients. Frontiers in Medicine. 2022; 9DOI:10.3389/fmed.2022.823900. PMID:35178413. IF:3.900(Q2/4D).